ArticleCureus2025
Reassessing the Necessity of Group and Save Testing in Ambulatory Orthopedic Peripheral Limb Trauma Surgery.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPreoperative group and save (G&S) testing is routinely ordered for patients undergoing ambulatory peripheral limb orthopedic trauma procedures due to anticipated perioperative blood loss. However, national and local guidance on this protocol is often ambiguous, leading to potentially unnecessary testing with associated economic and environmental costs. This study aimed to determine the incidence of red cell transfusion in adult patients undergoing ambulatory peripheral limb trauma surgery, quantify the prevalence of preoperative G&S testing, and identify patient and procedural factors associated with the ordering of G&S tests.
methodsThis retrospective cohort study included all adult patients undergoing ambulatory orthopedic procedures (open reduction internal fixation and K-wire surgeries) distal to the shoulder and knee joints at a single NHS trust over a 12-month period (July 2024-July 2025). Data collected included patient demographics, incidence of G&S testing, and perioperative red cell transfusion rates. Statistical analysis used univariable and multivariable models to identify predictors of G&S testing.
resultsA total of 459 patients (mean age 50.4+/-19.5 years), 157 (34.3%) had a G&S test performed, resulting in a total of 315 samples. The ankle was the site with the most frequent G&S testing (n=43, 62.6% of ankle procedures). American Society of Anaesthesiologists (ASA) grade 2 was the most frequent ASA grade (n=227, 49.5%). Mean preoperative hemoglobin was 132.1±18.3 g/L. One patient (0.21%) received a preoperative transfusion for pre-existing anemia. No patients received a postoperative red cell transfusion. Multivariable logistic regression found no clinical significance between demographics and the likelihood of G&S testing. Poisson regression analysis found that upper limb procedures were associated with significantly fewer tests (incidence rate ratio (IRR)=0.20, p=0.009), while higher ASA grade (p=0.024) and procedures involving the humerus/shoulder (IRR=3.0, p=0.037) were associated with increased G&S testing.
conclusionThis study demonstrates that routine preoperative G&S testing is not clinically required for many patients undergoing ambulatory peripheral limb orthopedic trauma surgery. Current testing practices, influenced by procedural site and patient comorbidity (ASA grade), contribute to a significant and unnecessary economic and environmental cost. Implementing a selective, risk-based institutional protocol is necessary to align practice with evidence, improve cost-effectiveness, and enhance the sustainability of orthopedic surgical care.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.